Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes

NCT01309698 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Vildagliptin (LAF237)
DRUG: Voglibose
DRUG: Vildagliptin and Voglibose

Sponsor

Novartis Pharmaceuticals